BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2369131)

  • 1. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
    Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
    J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.
    Araki Y; Ikebe M
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):679-84. PubMed ID: 1710106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
    Ikebe M
    Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
    Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
    J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure required for the inhibition of smooth muscle myosin light chain kinase.
    Ikebe M; Reardon S; Fay FS
    FEBS Lett; 1992 Nov; 312(2-3):245-8. PubMed ID: 1426258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1.
    Morrison DL; Sanghera JS; Stewart J; Sutherland C; Walsh MP; Pelech SL
    Biochem Cell Biol; 1996; 74(4):549-57. PubMed ID: 8960361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-dependent phosphorylation of myosin light chain kinase decreases the Ca2+ sensitivity of light chain phosphorylation within smooth muscle cells.
    Tansey MG; Luby-Phelps K; Kamm KE; Stull JT
    J Biol Chem; 1994 Apr; 269(13):9912-20. PubMed ID: 8144585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of zipper-interacting protein kinase function in smooth muscle by a myosin light chain kinase pseudosubstrate peptide.
    Ihara E; Edwards E; Borman MA; Wilson DP; Walsh MP; MacDonald JA
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1951-9. PubMed ID: 17215325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure and function of the actin-binding domain of myosin light chain kinase of smooth muscle.
    Ye LH; Hayakawa K; Kishi H; Imamura M; Nakamura A; Okagaki T; Takagi T; Iwata A; Tanaka T; Kohama K
    J Biol Chem; 1997 Dec; 272(51):32182-9. PubMed ID: 9405419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function.
    Smith MK; Colbran RJ; Soderling TR
    J Biol Chem; 1990 Feb; 265(4):1837-40. PubMed ID: 2153665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP/vanadate mediated photocleavage of myosin light chain kinase at the autoinhibitory region.
    Maruta S; Mitsuhashi S; Yamada M; Ikebe M
    J Biochem; 1998 Sep; 124(3):557-64. PubMed ID: 9722665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
    Bagchi IC; Kemp BE; Means AR
    Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin light chain kinase autoregulatory pseudosubstrate prototope.
    Pearson RB; Hunt JT; Mitchelhill KI; Kemp BE
    Pept Res; 1991; 4(3):147-53, 156-7. PubMed ID: 1823185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudosubstrate flexibility in chicken smooth muscle myosin light chain kinase.
    Barden JA; Kemp BE
    Biochem Biophys Res Commun; 1996 Jul; 224(3):690-5. PubMed ID: 8713108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of the C-terminal domain of smooth muscle myosin light chain kinase on the phosphorylation of smooth muscle myosin.
    Numata T; Katoh T; Yazawa M
    J Biochem; 2001 Mar; 129(3):437-44. PubMed ID: 11226884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boundary of the autoinhibitory region of smooth muscle myosin light-chain kinase.
    Yano K; Araki Y; Hales SJ; Tanaka M; Ikebe M
    Biochemistry; 1993 Nov; 32(45):12054-61. PubMed ID: 8218283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase.
    Lukas TJ; Burgess WH; Prendergast FG; Lau W; Watterson DM
    Biochemistry; 1986 Mar; 25(6):1458-64. PubMed ID: 3754463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.